Fit to Freeze
Better freezing through biology
Modern biological research and medicine depend on the frozen storage of hundreds of cell lines, blood, bone marrow, embryos, and even small organisms. But the technique of cryopreservation—using chemicals discovered more than 60 years ago—can be toxic to frozen cells and in some cases can fail to protect the cells completely.
But what if instead of looking for better physics and engineering-based ways to freeze human cells, asks Siniša Hrvatin, we find a way to equip those cells to survive the freeze, using molecular tools inspired by nature?
Hrvatin, a Freeman Hrabowski Howard Hughes Medical Institute Scholar, a Member of the Whitehead Institute, and the Thomas D. and Virginia W. Cabot Career Development Assistant Professor of Biology, will explore ways to engineer cells to withstand the toxicity of cryoprotective chemicals. He also plans to develop new bioinspired synthetic cryoprotectants for human tissue.
“If successful, this aim will produce human cells—initially cell lines, and eventually primary cells and tissues like the retina or pancreatic islets—that are more resilient to cryoprotectants and freezing,” he says.
From hibernation to cryopreservation
Hrvatin’s lab studies how mammals survive the cold and slow states of hibernation and torpor. But it was the researchers’ work on completely different animals called tardigrades, also known as water bears, that led him to reconsider the process of cryopreservation.
He and his colleagues discovered a class of proteins that the tardigrade uses to survive temperatures as low as -150°C. The researchers then used the proteins to engineer human cells with improved cold tolerance.
“Our success in improving human cell cold tolerance has inspired us to pivot into this new direction” Hrvatin says. “This is a high-risk, high-reward venture into largely uncharted territory, since few precedents exist for systematically improving human cell cryotolerance or creating nature-inspired cryoprotectants.”
Revolution in transplant medicine
Tardigrades are just the starting point—Hrvatin wants to investigate the antifreeze strategies deployed by other organisms such as freeze-tolerant plants, nematodes, rotifers, reptiles, and amphibians.
Once he and his colleagues have found a way to engineer individual human cells to survive the stress of freezing, they will tackle the “notorious” challenge of preserving whole tissues and organs, Hrvatin says.
“Currently, organs such as hearts or kidneys must be transplanted within hours of procurement because we cannot freeze and store them,” he explains. “With more freeze-tolerant cells and superior cryoprotectant cocktails … the ultimate goal is to achieve long-term storage of human organs for transplantation, which would be revolutionary for transplant medicine.”
